JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation

Thromb Haemost. 2007 Sep;98(3):681-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Budd-Chiari Syndrome / genetics*
  • Budd-Chiari Syndrome / surgery
  • Factor V / genetics*
  • Fatal Outcome
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Janus Kinase 2 / genetics*
  • Mutation*
  • Myeloproliferative Disorders / complications
  • Myeloproliferative Disorders / diagnosis*
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / surgery
  • Pedigree
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Risk Factors

Substances

  • factor V Leiden
  • Factor V
  • JAK2 protein, human
  • Janus Kinase 2